Have a personal or library account? Click to login

Possible association of ghrelin/obestatin balance with cardiometabolic risk in obese subjects with Helicobacter pylori

Open Access
|Apr 2018

References

  1. Aydemir S, Bayraktaroglu T, Sert M, Sokmen C, Atmaca H, Mungan G, Gun BD, Borazan A, Ustundag Y. The effect of Helicobacter pylori on insulin resistance. Dig Dis Sci 50, 2090–2093, 2005.10.1007/s10620-005-3012-z16240220
  2. Azuma T, Suto H, Ito Y, Ohtani M, Dojo M, Kuriyama M, Kato T. Gastric leptin and Helicobacter pylori infection. Gut 49, 324–329, 2001.10.1136/gut.49.3.324172844011511551
  3. Boltin D, Niv Y. Ghrelin, Helicobacter pylori and body mass: is there an association? Isr Med Assoc J 14, 130–132, 2012.
  4. Burtis CA, Ashwood ER, Bruns DE. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics (4th Ed.). Elsevier, Saunders, St. Louis, 2006.
  5. Buzas GM. Metabolic consequences of Helicobacter pylori infection and eradication. World J Gastroenterol 20, 5226–5234, 2014.10.3748/wjg.v20.i18.5226401703724833852
  6. Campana D, Nori F, Pagotto U, De Iasio R, Morselli-Labate AM, Pasquali R, Corinaldesi R, Tomassetti P. Plasma acylated ghrelin levels are higher in patients with chronic atrophic gastritis. Clin Endocrinol (Oxf), 67, 761–766, 2007.10.1111/j.1365-2265.2007.02959.x17614968
  7. Carabotti M, D’Ercole C, Iossa A, Corazziari E, Silecchia G, Severi C. Helicobacter pylori infection in obesity and its clinical outcome after bariatric surgery. World J Gastroenterol 20, 647–653, 2014.10.3748/wjg.v20.i3.647392147424574738
  8. Chen CY, Asakawa A, Fujimiya M, Lee SD, Inui A. Ghrelin gene products and the regulation of food intake and gut motility. Pharmacol Rev 61, 430–481, 2009.10.1124/pr.109.00195820038570
  9. Chevenne D, Letailleur A, Trivin F, Porquet D. Effect of hemolysis on the concentration of insulin in serum determined by RIA and IRMA. Clin Chem 44, 354–356, 2001.10.1093/clinchem/44.2.354
  10. Cho I, Blaser MJ, François F, Mathew JP, Ye XY, Goldberg JD, Bini EJ. Helicobacter pylori and overweight status in the United States: data from the third national health and nutrition examination survey. Am J Epidemiol 162, 579–84, 2005.10.1093/aje/kwi23716093294
  11. Choe YH, Lee JH, Lee HJ, Paik KH, Jin DK, Song SY, Lee JH. Ghrelin levels in gastric mucosa before and after eradication of H. pylori. Gut and Liver 1, 132–137, 2007.10.5009/gnl.2007.1.2.132287163120485629
  12. Choi J, Ko K, Lim J, Cheon E, Lee G, Yoon J. The association between Helicobacter pylori infection and body weight among children. Pediatr Gastroenterol Hepatol Nutr 19, 110–115, 2016.10.5223/pghn.2016.19.2.110494230827437187
  13. Chuang CH, Sheu BS, Yang HB, Lee SC, Kao AW, Cheng HC, Chang WL, Yao WJ. Gender difference of circulating ghrelin and leptin concentrations in chronic Helicobacter pylori infection. Helicobacter 14, 54–60, 2009.10.1111/j.1523-5378.2009.00653.x
  14. Cindoruk M, Yetkin I, Deger SM, Karakan T, Kan E, Unal S. Influence of H. pylori on plasma ghrelin in patients without atrophic gastritis. World J Gastroenterol 13, 1595–1598, 2007.10.3748/wjg.v13.i10.1595
  15. Deng ZH, Chu B, Xu YZ, Zhang B, Jiang LR. Influence of H. pylori infection on Ghrelin levels in children. World J Gastroenterol 18, 5096–5100, 2012.10.3748/wjg.v18.i36.5096
  16. Du T, Sun X, Yin P, Huo R, Ni C, Yu X. Increasing trends in central obesity among Chinese adults with normal body mass index, 1993–2009. BMC Public Health 13, 327, 2013.10.1186/1471-2458-13-327
  17. Ericksen RE, Rose S, Westphalen CB, Shibata W, Muthupalani S, Tailor Y, Friedman RA, Han W, Fox JG, Ferrante AW Jr, Wang TC. Obesity accelerates Helicobacter felis-induced gastric carcinogenesis by enhancing immature myeloid cell trafficking and TH17 response. Gut 63, 385–394, 2014.10.1136/gutjnl-2013-305092
  18. Fernandez-Real JM, Pickup JC. Innate immunity, insulin resistance and type 2 diabetes. Trends Endocrinol Metab 19, 10–16, 2008.10.1016/j.tem.2007.10.004
  19. Fujiwara Y, Higuchi K, Arafa UA, Uchida T, Tominaga K, Watanabe T, Arakawa T. Long-term effect of Helicobacter pylori eradication on quality of life, body mass index, and newly developed diseases in Japanese patients with peptic ulcer disease. Hepatogastroenterology 49, 1298–1302, 2002.
  20. Garrow JS, Webster J. Quetelet’s index (W/H2) as a measure of fatness. Int J Obes 9, 147–153, 1985.
  21. Gen R, Demir M, Ataseven H. Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and lowgrade inflammation. South Med J 103, 190–196, 2010.10.1097/SMJ.0b013e3181cf373f
  22. Gokcel A, Gumurdulu Y, Kayaselcuk F, Serin E, Ozer B, Ozsahin AK, Guvener N. Helicobacter pylori has no effect on plasma ghrelin levels. Eur J Endocrinol 148, 423–442, 2003.10.1530/eje.0.1480423
  23. Goodwin CS, Mendall MM, Northfield TC. Helicobacter pylori infection. Lancet 349, 265–269, 1997.10.1016/S0140-6736(96)07023-7
  24. Hassouna R, Zizzari P, Tolle V. The ghrelin/obestatin balance in the physiological and pathological control of growth hormone secretion, body composition and food intake. J Neuroendocrinol 22, 793–804, 2010.10.1111/j.1365-2826.2010.02019.x20456603
  25. Huda MS, Durham BH, Wong SP, Deepak D, Kerrigan D, McCulloch P, Ranganath L, Pinkney J, Wilding JP. Plasma obestatin levels are lower in obese and post-gastrectomy subjects, but do not change in response to a meal. Int J Obes 32, 129–135, 2008.10.1038/sj.ijo.080369417667911
  26. Cui H, Lopez M, Rahmouni K. The cellular and molecular bases of leptin and ghrelin resistance in obesity. Nat Rev Endocrinol 13, 338–351, 2017.10.1038/nrendo.2016.222890408328232667
  27. Jeffery PL, McGuckin MA, Linden SK. Endocrine impact of Helicobacter pylori: focus on ghrelin and ghrelin oacyltransferase. World J Gastroenterol 17, 1249–1260, 2011.10.3748/wjg.v17.i10.1249306825921455323
  28. Khosravi Y, Bunte RM, Chiow KH, Tan TL, Wong WY, Poh QH, Doli Sentosa IM, Seow SW, Amoyo AA, Pettersson S, Loke MF, Vadivelu J. Helicobacter pylori and gut microbiota modulate energy homeostasis prior to inducing histopathological changes in mice. Gut Microbes 7, 48–53, 2016.10.1080/19490976.2015.1119990485646426939851
  29. Kim TJ, Lee H, Kang M, Kim JE, Choi YH, Min YW Min BH, Lee JH, Son HJ, Rhee PL, Baek SY, Ahn SH, Kim JJ. Helicobacter pylori is associated with dyslipidemia but not with other risk factors of cardiovascular disease. Sci Rep 6, 38015, 2016.10.1038/srep38015512509227892538
  30. Lee ES1, Yoon YS, Park CY, Kim HS, Um TH, Baik HW, Jang EJ, Lee S, Park HS, Oh SW. Eradication of Helicobacter pylori increases ghrelin mRNA expression in the gastric mucosa. J Korean Med Sci 25, 265–271, 2010.10.3346/jkms.2010.25.2.265281129520119581
  31. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419, 1985.10.1007/BF002808833899825
  32. Stec-Michalska K, Malicki S, Michalski B, Peczek L, Wisniewska-Jarosinska M, Nawrot B. Gastric ghrelin in relation to gender, stomach topography and Helicobacter pylori in dyspeptic patients. World J Gastroenterol 15, 5409–5417, 2009.10.3748/wjg.15.5409277809619916170
  33. Nwokolo CU, Freshwater DA, O’Hare P, Randeva HS. Plasma ghrelin following cure of Helicobacter pylori. Gut 52, 637–640, 2003.10.1136/gut.52.5.637177363412692045
  34. Osawa H, Nakazato M, Date Y, Kita H, Ohnishi H, Ueno H, Shiiya T, Satoh K, Ishino Y, Sugano K. Impaired production of gastric ghrelin in chronic gastritis associated with Helicobacter pylori. J Clin Endocrinol Metab 90, 10–16, 2005.10.1210/jc.2004-133015483107
  35. Osawa H. Ghrelin and Helicobacter pylori infection. World J Gastroenterol 14, 6327–6333, 2008.10.3748/wjg.14.6327276611319009647
  36. Quatrini M, Boarino V, Ghidoni A, Baldassarri AR, Bianchi PA, Bardella MT. Helicobacter pylori prevalence in patients with diabetes and its relationship to dyspeptic symptoms. J Clin Gastroenterol 32, 215–217, 2001.10.1097/00004836-200103000-0000611246346
  37. Satoh H, Saijo Y, Yoshioka E, Tsutsui H. Helicobacter Pylori infection is a significant risk for modified lipid profile in Japanese male subjects. J Atheroscler Thromb 17, 1041–1048, 2010.10.5551/jat.515720610892
  38. Sotiropoulos A, Gikas A, Skourtis S, Merkouris P, Pentzeridis P, Polydorou A, Pappas S. Seropositivity to Chlamydia pneumoniae or Helicobacter pylori and coronary artery disease. Int J Cardiol 109, 420–421, 2006.10.1016/j.ijcard.2005.05.03915993502
  39. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 27, 1487–1495, 2004.10.2337/diacare.27.6.148715161807
  40. Ulasoglu C, Isbilen B, Doganay L, Ozen F. Effect of Helicobacter pylori eradication on serum ghrelin and obestatin levels. World J Gastroenterol 19, 2388–2394, 2013.10.3748/wjg.v19.i15.2388363199223613634
  41. Yildiz B, Suchard M, Wong M, McCann S, Licinio J. Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity. Proc Natl Acad Sci USA 101, 10434–10439, 2004.10.1073/pnas.040346510147860115231997
  42. Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch R, Klein C, Hsueh AJ. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin’s effects on food intake. Science 310, 996–999, 2005.10.1126/science.111725516284174
  43. Zhang Y, Du T, Chen X, Yu X, Tu L, Zhang C. Association between Helicobacter pylori infection and overweight or obesity in a Chinese population. J Infect Dev Ctries 9, 945–953, 2015.10.3855/jidc.603526409735
DOI: https://doi.org/10.2478/enr-2018-0012 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668
Language: English
Page range: 101 - 109
Published on: Apr 30, 2018
Published by: Slovak Academy of Sciences, Mathematical Institute
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2018 Azza Saad Ibrahim, Mona Mohamed Eldeeb, Ola Ahmed Salama, Mona Mohamed Rashad, Khaled Mohamed Okasha, published by Slovak Academy of Sciences, Mathematical Institute
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.